Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
UBS
US Army
Covington
Chubb
QuintilesIMS
Queensland Health
Farmers Insurance

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020500

« Back to Dashboard

NDA 020500 describes MEPRON, which is a drug marketed by Glaxosmithkline Llc and is included in two NDAs. It is available from two suppliers. Additional details are available on the MEPRON profile page.

The generic ingredient in MEPRON is atovaquone. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atovaquone profile page.
Summary for 020500
Tradename:MEPRON
Applicant:Glaxosmithkline Llc
Ingredient:atovaquone
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Pharmacology for NDA: 020500
Medical Subject Heading (MeSH) Categories for 020500
Suppliers and Packaging for NDA: 020500
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEPRON atovaquone SUSPENSION;ORAL 020500 NDA GlaxoSmithKline LLC 0173-0547 N 0173-0547-00
MEPRON atovaquone SUSPENSION;ORAL 020500 NDA GlaxoSmithKline LLC 0173-0665 N 0173-0665-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength750MG/5ML
Approval Date:Feb 8, 1995TE:ABRLD:Yes

Expired US Patents for NDA 020500

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc MEPRON atovaquone SUSPENSION;ORAL 020500-001 Feb 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Llc MEPRON atovaquone SUSPENSION;ORAL 020500-001 Feb 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Llc MEPRON atovaquone SUSPENSION;ORAL 020500-001 Feb 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Mallinckrodt
Baxter
Boehringer Ingelheim
Chinese Patent Office
Deloitte
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.